Literature DB >> 11138974

P2 receptor agonists stimulate insulin release from human pancreatic islets.

J Fernandez-Alvarez1, D Hillaire-Buys, M M Loubatières-Mariani, R Gomis, P Petit.   

Abstract

Although P2 receptors for adenosine 5'-triphosphate (ATP) and/or adenosine 5'-diphosphate (ADP) have been characterized in mammalian pancreatic beta cells, no evidence for an insulin-secreting effect of P2 receptor agonists has been reported as yet in humans. The present study aimed at investigating whether P2 receptor agonists could stimulate insulin release in human pancreatic islets obtained from brain-dead organ donors. Experiments were performed using different glucose concentrations and insulin was measured by radioimmunoassay. When the glucose concentration (8.3 mmol/L) was slightly stimulating for insulin release, alpha,beta-methylene ATP (200 micromol/L) and ADPbetaS (50 micromol/L) similarly amplified insulin secretion: both compounds induced a threefold increase in insulin response. In the presence of a nonstimulating glucose concentration (3.0 mmol/L), only alpha,beta-methylene ATP could induce a significant 1.4-fold increase in insulin release, ADPbetaS being completely ineffective. These results give evidence that P2 receptor agonists are effective in stimulating insulin release in humans, the effect of the P2Y agonist being essentially glucose dependent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11138974     DOI: 10.1097/00006676-200101000-00012

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  28 in total

1.  Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.

Authors:  R Gnana Ravi; Hak Sung Kim; Jörg Servos; Herbert Zimmermann; Kyeong Lee; Savitri Maddileti; José L Boyer; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

Review 2.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

3.  A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.

Authors:  Shay Eliahu; Haim M Barr; Jean Camden; Gary A Weisman; Bilha Fischer
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

4.  Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion.

Authors:  Clintoria Richards-Williams; Juan L Contreras; Kathleen H Berecek; Erik M Schwiebert
Journal:  Purinergic Signal       Date:  2008-10-23       Impact factor: 3.765

5.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

6.  ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells.

Authors:  Chanyuan Tan; Albert Salehi; Siv Svensson; Björn Olde; David Erlinge
Journal:  Cell Mol Life Sci       Date:  2009-11-14       Impact factor: 9.261

7.  Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.

Authors:  Shir Yelovitch; Haim M Barr; Jean Camden; Gary A Weisman; Ela Shai; David Varon; Bilha Fischer
Journal:  J Med Chem       Date:  2012-08-20       Impact factor: 7.446

8.  The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice.

Authors:  Antonia Sassmann; Belinda Gier; Hermann-Josef Gröne; Gisela Drews; Stefan Offermanns; Nina Wettschureck
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

9.  ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice.

Authors:  S Amisten; S Meidute-Abaraviciene; C Tan; B Olde; I Lundquist; A Salehi; D Erlinge
Journal:  Diabetologia       Date:  2010-06-06       Impact factor: 10.122

10.  P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.

Authors:  Anne Farret; Romain Filhol; Nathalie Linck; Michèle Manteghetti; Jacques Vignon; René Gross; Pierre Petit
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.